167 related articles for article (PubMed ID: 30023485)
21. Subcellular expression pattern and clinical significance of CBX2 and CBX7 in breast cancer subtypes.
Park S; Choi J; Song JK; Jang B; Maeng YH
Med Mol Morphol; 2024 Mar; 57(1):11-22. PubMed ID: 37553450
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis.
Meng X; Cao R; Liu X; Fu B; Luo L; Jiang M; Wang K; Liu Y; Zhu Q; Yang C; Zhou L
Oncol Lett; 2023 Apr; 25(4):172. PubMed ID: 36970607
[TBL] [Abstract][Full Text] [Related]
23. Rational Adaptation of L3MBTL1 Inhibitors to Create Small-Molecule Cbx7 Antagonists.
Simhadri C; Daze KD; Douglas SF; Milosevich N; Monjas L; Dev A; Brown TM; Hirsch AKH; Wulff JE; Hof F
ChemMedChem; 2019 Aug; 14(15):1444-1456. PubMed ID: 31254321
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma.
Zhu Y; Pu Z; Li Z; Lin Y; Li N; Peng F
Front Oncol; 2021; 11():700528. PubMed ID: 34395271
[TBL] [Abstract][Full Text] [Related]
25. Discovery of Potent Peptidomimetic Antagonists for Heterochromatin Protein 1 Family Proteins.
Lamb KN; Dishman SN; Waybright JM; Engelberg IA; Rectenwald JM; Norris-Drouin JL; Cholensky SH; Pearce KH; James LI; Frye SV
ACS Omega; 2022 Jan; 7(1):716-732. PubMed ID: 35036738
[TBL] [Abstract][Full Text] [Related]
26. How CBX proteins regulate normal and leukemic blood cells.
de Groot AP; de Haan G
FEBS Lett; 2024 Mar; ():. PubMed ID: 38426219
[TBL] [Abstract][Full Text] [Related]
27. Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX Chromodomains.
Stuckey JI; Simpson C; Norris-Drouin JL; Cholensky SH; Lee J; Pasca R; Cheng N; Dickson BM; Pearce KH; Frye SV; James LI
J Med Chem; 2016 Oct; 59(19):8913-8923. PubMed ID: 27571219
[TBL] [Abstract][Full Text] [Related]
28. Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7.
Lamb KN; Bsteh D; Dishman SN; Moussa HF; Fan H; Stuckey JI; Norris JL; Cholensky SH; Li D; Wang J; Sagum C; Stanton BZ; Bedford MT; Pearce KH; Kenakin TP; Kireev DB; Wang GG; James LI; Bell O; Frye SV
Cell Chem Biol; 2019 Oct; 26(10):1365-1379.e22. PubMed ID: 31422906
[TBL] [Abstract][Full Text] [Related]
29. Aza-amino acid scanning of chromobox homolog 7 (CBX7) ligands.
Traoré M; Gignac M; Doan ND; Hof F; Lubell WD
J Pept Sci; 2017 Apr; 23(4):266-271. PubMed ID: 28220557
[TBL] [Abstract][Full Text] [Related]
30. Polycomb chromobox (Cbx) 7 modulates activation-induced CD4+ T cell apoptosis.
Li J; Li Y; Cao Y; Yuan M; Gao Z; Guo X; Zhu F; Wang Y; Xu J
Arch Biochem Biophys; 2014 Dec; 564():184-8. PubMed ID: 25449062
[TBL] [Abstract][Full Text] [Related]
31. Novel chromobox 2 inhibitory peptide decreases tumor progression.
Brubaker LW; Backos DS; Nguyen VT; Reigan P; Yamamoto TM; Woodruff ER; Iwanaga R; Wempe MF; Kumar V; Persenaire C; Watson ZL; Bitler BG
Expert Opin Ther Targets; 2023; 27(4-5):361-371. PubMed ID: 37243607
[TBL] [Abstract][Full Text] [Related]
32. CBX7 Induces Self-Renewal of Human Normal and Malignant Hematopoietic Stem and Progenitor Cells by Canonical and Non-canonical Interactions.
Jung J; Buisman SC; Weersing E; Dethmers-Ausema A; Zwart E; Schepers H; Dekker MR; Lazare SS; Hammerl F; Skokova Y; Kooistra SM; Klauke K; Poot RA; Bystrykh LV; de Haan G
Cell Rep; 2019 Feb; 26(7):1906-1918.e8. PubMed ID: 30759399
[TBL] [Abstract][Full Text] [Related]
33. The predictive significance of chromobox family members in prostate cancer in humans.
Xu X; Lai C; Luo J; Shi J; Guo K; Hu J; Mulati Y; Xiao Y; Kong D; Liu C; Huang J; Xu K
Cell Oncol (Dordr); 2024 Mar; ():. PubMed ID: 38427207
[TBL] [Abstract][Full Text] [Related]
34. Pan-cancer analysis of Chromobox (CBX) genes for prognostic significance and cancer classification.
Naqvi AAT; Rizvi SAM; Hassan MI
Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166561. PubMed ID: 36183965
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic value of Chromobox family members in gastric cancer.
Ma T; Ma N; Chen JL; Tang FX; Zong Z; Yu ZM; Chen S; Zhou TC
J Gastrointest Oncol; 2020 Oct; 11(5):983-998. PubMed ID: 33209492
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of the Expression and Prognosis of chromobox Family Members in Breast Cancer.
Wang L; Zhao L; Zhang Y; Shao S; Ning Q; Zhao X; Luo M
Clin Breast Cancer; 2023 Jun; 23(4):e206-e218. PubMed ID: 36890004
[TBL] [Abstract][Full Text] [Related]
37. Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer.
Li X; Li L; Xiong X; Kuang Q; Peng M; Zhu K; Luo P
Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189494
[TBL] [Abstract][Full Text] [Related]
38. Mining Transcriptomic Data to Uncover the Association between CBX Family Members and Cancer Stemness.
Czerwinska P; Mackiewicz AA
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361869
[TBL] [Abstract][Full Text] [Related]
39. A human Polycomb isoform lacking the Pc box does not participate to PRC1 complexes but forms protein assemblies and represses transcription.
Völkel P; Le Faou P; Vandamme J; Pira D; Angrand PO
Epigenetics; 2012 May; 7(5):482-91. PubMed ID: 22419124
[TBL] [Abstract][Full Text] [Related]
40. Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein.
Federico A; Pallante P; Bianco M; Ferraro A; Esposito F; Monti M; Cozzolino M; Keller S; Fedele M; Leone V; Troncone G; Chiariotti L; Pucci P; Fusco A
Cancer Res; 2009 Sep; 69(17):7079-87. PubMed ID: 19706751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
